485F US Highway One South
Suite 210
Iselin, NJ 08830
tel. 732.596.0276
fax 732.647.1235
Davy James
Group Editorial Director
djames@mjhlifesciences.com
Andrew Studna
Editor
astudna@mjhlifesciences.com
Michael Christel
Group Managing Editor
mchristel@mjhlifesciences.com
Miranda Schmalfuhs
Group Social Media Editor
mschmalfuhs@mjhlifesciences.com
An Examination of the Use of Patient Recruitment and Retention Tactics for Global Studies
March 18th 2024In light of scant published data from sponsors and contract research organizations on site activation and recruitment challenges following the COVID-19 pandemic, the primary objective of this research is to revisit the results of recruitment and retention tactics in studies conducted in 2012 and 2019.
Phase III THARROS Trial to Evaluate Impact of Breztri Aerosphere on Cardiopulmonary Outcomes in COPD
March 14th 2024THARROS trial investigators seek to provide first-of-its-kind evidence supporting a strategy of comprehensive cardiopulmonary risk reduction with a triple therapy in patients with chronic obstructive pulmonary disease.